Has Roy Davidovitch received payments from drug or device companies?

Yes. Drug and device makers reported $328,641 in general payments to Roy Davidovitch across 62 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Roy Davidovitch did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Roy Davidovitch come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Roy Davidovitch

Orthopaedic Surgery · New York, NYNPI 1619952801

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $287,625 of the $328,641 with a category attached, or 87.5%. Exactech, Inc. accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $68,695 and has fallen 56.3% since, to $30,027 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$328,641in general payments, 2019–2025

Across 62 payments — averaging $5300.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Exactech, Inc.$328K
Stryker$777
Zimmer Biomet$127
Johnson & Johnson$109
DJO, LLC$50
Bioventus LLC$27

$13,993in research payments, 2019–2025

Across 2 payments — averaging $6996.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Exactech, Inc.$14K

What the payments were for

Royalty or licence$287,62588%
Consulting fees$35,50011%
Travel & lodging$3,3991%
Food & beverage$1,9521%
Education$1650%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Exactech, Inc.	51	$327,552
Stryker	7	$777
Zimmer Biomet	1	$127
Johnson & Johnson	1	$109
DJO, LLC	1	$50
Bioventus LLC	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$328,641 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	51	$239
Famotidine	29	$146
Ondansetron Hcl	41	$134
Amoxicillin	27	$119
Tramadol Hcl	37	$115
Diclofenac Sodium	25	$108
Cephalexin	29	$94
Clindamycin Hcl	14	$44
Oxycodone Hcl	11	$36

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

Anthony RomeoNew York$26.8M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →